Subclinical Hypothyroidism With Overt Symptoms in Patient With Well-Controlled Epilepsy on Valproate Therapy: A Case
Samarth Doshi1, Kelly A Denhard2, Kathryn Li Xixis3
1Department of Pediatrics, Northwestern University's Feinberg School of Medicine and The Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Abstract:
Valproate is known to have various adverse effects including hormonal dysfunction. There is debate in literature regarding the association between valproate therapy and subclinical hypothyroidism, with some studies suggesting a potential link. However, none of the studies on our review have noted overt hypothyroid symptoms with subclinical hypothyroidism. We present a pediatric patient with generalized epilepsy on long-term valproate therapy who developed subclinical hypothyroidism with overt hypothyroid symptoms. Our patient initially presented as a 3-year-old with absence epilepsy and was well-controlled with valproate monotherapy. After more than 2 years of seizure freedom, the patient developed symptoms of hypothyroidism, leading to a diagnosis of grade 2 subclinical hypothyroidism. Symptom resolution occurred with discontinuation of valproate and with initiation of levothyroxine. Ultimately, thyroid studies normalized, and levothyroxine was also discontinued. Although subclinical hypothyroidism is a known potential side effect of valproate therapy, this case demonstrates that overt hypothyroid symptoms are rare, but possible.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...


